These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Opportunistic microorganisms: the causative agents of food toxicoinfections and acute intestinal diseases]. Kalina GP; Kharitonov NS Zh Mikrobiol Epidemiol Immunobiol; 1982; (11):82-6. PubMed ID: 6218719 [TBL] [Abstract][Full Text] [Related]
25. [The possibilities for correcting the dysbacteriosis occurring in the prolonged external diversion of bile]. Shor-Chudnovskiĭ ME; Susak IaM; Grigor'ev AV; Kurik MV; Shelkovaia NG Klin Khir (1962); 1993; (11):30-2. PubMed ID: 8207906 [TBL] [Abstract][Full Text] [Related]
26. [Monkeys as subjects for study of immunobiological preparations]. Aleshkin VA; Lapin BA; Afanas'ev SS; Pospelova VV; Dzhikidze EK; Afanas'ev MS Vestn Ross Akad Med Nauk; 2006; (2):11-5. PubMed ID: 16544898 [TBL] [Abstract][Full Text] [Related]
28. Norfloxacin in the eradication of enteric infections in AIDS patients. Heseltine PN; Causey DM; Appleman MD; Corrado ML; Leedom JM Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S25-8. PubMed ID: 3280324 [TBL] [Abstract][Full Text] [Related]
29. [Optimization of treatment of children with acute intestinal infections by application of Russian biological microbial preparations]. Feklisova LV Vestn Ross Akad Med Nauk; 2005; (12):17-24. PubMed ID: 16404978 [TBL] [Abstract][Full Text] [Related]
30. Eradication of non-typhi Salmonella colonization by ciprofloxacin: implications for health care workers and institutionalized patients. Eng RH; Smith SM; Lo W; Lowe WC Am J Med; 1990 Sep; 89(3):386-8. PubMed ID: 2393044 [No Abstract] [Full Text] [Related]
31. Ciprofloxacin in the elimination of enteric Salmonella carriage stage. Lähdevirta J Scand J Infect Dis Suppl; 1989; 60():112-5. PubMed ID: 2667103 [TBL] [Abstract][Full Text] [Related]
33. [The efficacy of using bifidokefir for the treatment of acute intestinal infections and for the correction of dysbacterosis in children]. Murashova AO; Novokshonov AA; Uchaĭkin VF Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):108-10. PubMed ID: 7879497 [No Abstract] [Full Text] [Related]
34. Probiotic therapy: a real tool to reduce intestinal infections? Nava GM; Davila V Med Sci Monit; 2004 Nov; 10(11):LE22-3. PubMed ID: 15507860 [No Abstract] [Full Text] [Related]
35. [Effects of nifuroxazide (Ercefuryl), trimethoprim-sulfamethoxazole and bactisubtil in acute diarrhea]. Bulbulović-Telalbasić S Med Arh; 1991; 45(3-4):105-7. PubMed ID: 1366328 [TBL] [Abstract][Full Text] [Related]
36. [The microbiocenosis of the intestines and its influence on the course of postenterocolitic reactive arthritis]. Rubtsov OV; Bevz NI; Agababova ER; Goncharova GI Revmatologiia (Mosk); 1990; (2):46-50. PubMed ID: 2218264 [TBL] [Abstract][Full Text] [Related]
37. [Use of colibacterin in children with dysentery and in some other intestinal infections]. Riabinskaia TF; Kanshina OA; D'iakova EI; Koroleva AI Vopr Okhr Materin Det; 1967 Jun; 12(7):89-90. PubMed ID: 4887098 [No Abstract] [Full Text] [Related]
39. In vitro and in vivo examination of anticolonization of pathogens by Lactobacillus paracasei FJ861111.1. Deng K; Chen T; Wu Q; Xin H; Wei Q; Hu P; Wang X; Wang X; Wei H; Shah NP J Dairy Sci; 2015 Oct; 98(10):6759-66. PubMed ID: 26254535 [TBL] [Abstract][Full Text] [Related]
40. [Pre-and probiotics effectiveness in intestine microbiocenosis correction in patients after hemicolectomy]. Li AI; Sil'vestrova SIu Eksp Klin Gastroenterol; 2011; (6):49-54. PubMed ID: 22168078 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]